Ito, Masaaki
Iwama, Shintaro
Sugiyama, Daisuke
Yasuda, Yoshinori
Okuji, Takayuki
Kobayashi, Tomoko
Zhou, Xin
Yamagami, Ayana
Onoue, Takeshi
Miyata, Takashi
Sugiyama, Mariko
Hagiwara, Daisuke
Suga, Hidetaka
Banno, Ryoichi
Nishikawa, Hiroyoshi
Arima, Hiroshi
Funding for this research was provided by:
JSPS KAKENHI (JP 16K195552)
Article History
Received: 17 November 2022
Accepted: 6 April 2023
First Online: 12 April 2023
Competing interests
: H.N. received research funding and honoraria from Ono Pharmaceutical, MSD, Bristol-Myers Squibb and Chugai Pharmaceutical and research funding from Taiho Pharmaceutical, Daiichi-Sankyo, Kyowa Kirin, Zenyaku Kogyo, Oncolys BioPharma, Debiopharma, Asahi-Kasei, Sysmex, Fujifilm, SRL, Astellas Pharmaceutical, Sumitomo Dainippon Pharma and BD Japan outside of this study. M.I., S.I., D.S., Y.Y., T.O., T.K., X.Z., A.Y., T.O., T.M., M.S., D.H., H.S., R.B., and H.A. declare no potential conflict of interest.